4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-16-003843
CIK 0001597553operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:11 PM ET
Size
8.7 KB
Accession
0001562180-16-003843
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2016-12-15−1,900→ 165,138 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (1,900 underlying) - Tax Payment
Common Stock
2016-12-15$48.99/sh−346$16,951→ 1,554 total - Exercise/Conversion
Common Stock
2016-12-15$8.92/sh+1,900$16,948→ 1,900 total
Footnotes (2)
- [F1]The disposition reported on this Form 4 were effected pursuant to a stock swap using existing employee stock purchase (espp) shares.
- [F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:11 PM ET
- Size
- 8.7 KB